| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.07. | ULTRAGREEN.AI LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST OF DIRECTOR - TAN NG KUANG | 1 | SGX Company Announcements | ||
| 13.07. | ULTRAGREEN.AI LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::NOTIFICATION OF RESULTS RELEASE | - | SGX Company Announcements | ||
| 03.07. | ULTRAGREEN.AI LIMITED: EMPLOYEE STOCK OPTION/SHARE SCHEME::GRANT OF OPTIONS PURSUANT TO THE ULTRAGREEN.AI SHARE OPTION SCHEME | 1 | SGX Company Announcements | ||
| 29.06. | ULTRAGREEN.AI LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST OF DIRECTOR AND CHIEF EXECUTIVE OFFICER - RAVINDER SAJWAN | 3 | SGX Company Announcements | ||
| ULTRAGREEN.AI Aktie jetzt für 0€ handeln | |||||
| 26.06. | ULTRAGREEN.AI LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST OF DIRECTOR AND CHIEF EXECUTIVE OFFICER - RAVINDER SAJWAN | 1 | SGX Company Announcements | ||
| 25.06. | ULTRAGREEN.AI LIMITED: SHARE BUY BACK - DAILY SHARE BUY-BACK NOTICE::SHARE BUY BACK - DAILY SHARE BUY-BACK NOTICE | 2 | SGX Company Announcements | ||
| 24.06. | ULTRAGREEN.AI LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST OF DIRECTOR AND CHIEF EXECUTIVE OFFICER - RAVINDER SAJWAN | - | SGX Company Announcements | ||
| 17.06. | ULTRAGREEN.AI LIMITED: SHARE BUY BACK - DAILY SHARE BUY-BACK NOTICE::SHARE BUY BACK - DAILY SHARE BUY-BACK NOTICE | 2 | SGX Company Announcements | ||
| 15.06. | ULTRAGREEN.AI LIMITED: SHARE BUY BACK - DAILY SHARE BUY-BACK NOTICE::SHARE BUY BACK - DAILY SHARE BUY-BACK NOTICE | 1 | SGX Company Announcements | ||
| 11.06. | ULTRAGREEN.AI LIMITED: SHARE BUY BACK - DAILY SHARE BUY-BACK NOTICE::SHARE BUY BACK - DAILY SHARE BUY-BACK NOTICE | 1 | SGX Company Announcements | ||
| 04.06. | ULTRAGREEN.AI LIMITED: SHARE BUY BACK - DAILY SHARE BUY-BACK NOTICE::SHARE BUY BACK - DAILY SHARE BUY-BACK NOTICE | 1 | SGX Company Announcements | ||
| 02.06. | ULTRAGREEN.AI LIMITED: SHARE BUY BACK - DAILY SHARE BUY-BACK NOTICE::SHARE BUY BACK - DAILY SHARE BUY-BACK NOTICE | 1 | SGX Company Announcements | ||
| 02.06. | ULTRAGREEN.AI LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST OF DIRECTOR AND CHIEF EXECUTIVE OFFICER - RAVINDER SAJWAN | 1 | SGX Company Announcements | ||
| 28.05. | ULTRAGREEN.AI LIMITED: REPL::SHARE BUY BACK - DAILY SHARE BUY-BACK NOTICE::SHARE BUY BACK - DAILY SHARE BUY-BACK NOTICE | 1 | SGX Company Announcements | ||
| 28.05. | ULTRAGREEN.AI LIMITED: SHARE BUY BACK - DAILY SHARE BUY-BACK NOTICE::SHARE BUY BACK - DAILY SHARE BUY-BACK NOTICE | 6 | SGX Company Announcements | ||
| 22.05. | ULTRAGREEN.AI LIMITED: GENERAL ANNOUNCEMENT::MINUTES OF ANNUAL GENERAL MEETING HELD ON 24 APRIL 2026 | - | SGX Company Announcements | ||
| 20.05. | UltraGreen.ai invests $12.3m in LifeSignals, IHLD | 2 | Singapore Business Review | ||
| 18.05. | ULTRAGREEN.AI LIMITED: GENERAL ANNOUNCEMENT::USE OF IPO PROCEEDS | 1 | SGX Company Announcements | ||
| 18.05. | ULTRAGREEN.AI LIMITED: GENERAL ANNOUNCEMENT::INVESTOR DECK | 1 | SGX Company Announcements | ||
| 08.05. | ULTRAGREEN.AI LIMITED: GENERAL ANNOUNCEMENT::IMPLEMENTATION OF DUAL CURRENCY TRADING FOR ULTRAGREEN.AI LIMITED ON SGX-ST | - | SGX Company Announcements |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 36,860 | -0,91 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 59,71 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| FRESENIUS | 44,520 | -0,80 % | Aktien Frankfurt: 'Old economy' schiebt Dax weiter in Richtung Rekordhoch | FRANKFURT (dpa-AFX) - Die weiter nachgebenden Energiepreise haben am deutschen Aktienmarkt am Dienstag für weitere Entspannung gesorgt. Der Dax knüpfte gegen Mittag mit plus 0,61 Prozent auf 25.517... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 44,450 | +0,36 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 14,855 | +0,03 % | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 23,670 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 30,500 | +0,26 % | EQS-AFR: Carl Zeiss Meditec AG: Vorabbekanntmachung über die Veröffentlichung von Quartalsberichten und Quartals-/Zwischenmitteilungen | EQS Vorabbekanntmachung Finanzberichte: Carl Zeiss Meditec AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Carl Zeiss Meditec AG: Vorabbekanntmachung... ► Artikel lesen | |
| BILLIONTOONE | 138,54 | -0,04 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| GENEDX | 65,07 | -0,06 % | NSE - GeneDx Holdings Corp. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| HEARTFLOW | 25,230 | 0,00 % | Baird startet Coverage für HeartFlow mit "Outperform" | ||
| MANGOCEUTICALS | 0,558 | +0,14 % | Nuclea Energy Inc: Nuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactor | Mississauga, Ontario--(Newsfile Corp. - July 30, 2026) - Nuclea Energy Inc. ("Nuclea" or the "Company"), an advanced nuclear technology company headquartered in Mississauga, Ontario, developing... ► Artikel lesen | |
| BETA BIONICS | 12,820 | -0,08 % | Beta Bionics, Inc.: Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance | IRVINE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| DRAEGERWERK | 109,40 | +2,63 % | Draegerwerk AG & Co. KGaA: Die endgültigen Ergebnisse für das zweite Quartal bestätigen den operativen Fortschritt; Kursziel und KAUFEN bekräftigt. | Die endgültigen Ergebnisse von Drägerwerk (Dräger) für das zweite Quartal 2026 bestätigten die vorläufigen Zahlen und untermauerten die Erwartung an eine nachhaltige operative Erholung. Der Umsatz stieg... ► Artikel lesen | |
| PROGYNY | 31,130 | 0,00 % | Barclays downgrades Progyny stock rating on utilization concerns | ||
| GERRESHEIMER | 27,540 | -1,01 % | UBS stuft GERRESHEIMER AG auf 'Sell' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Gerresheimer auf "Sell" mit einem Kursziel von 12,90 Euro belassen. Olivier Calvet passte in einer am Montag vorliegenden... ► Artikel lesen |